Prestige Biologics Co., Ltd. (KOSDAQ:334970)
South Korea
· Delayed Price · Currency is KRW
3,235.00
+15.00 (0.47%)
At close: Dec 5, 2025
Prestige Biologics Ratios and Metrics
Market cap in millions KRW. Fiscal year is July - June.
Millions KRW. Fiscal year is Jul - Jun.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 4, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 251,530 | 283,797 | 245,391 | 272,542 | 184,546 | 453,181 | |
| Market Cap Growth | -48.67% | 15.65% | -9.96% | 47.68% | -59.28% | - | |
| Enterprise Value | 339,874 | 364,568 | 378,645 | 369,331 | 283,846 | 447,789 | |
| Last Close Price | 3235.00 | 3650.00 | 3990.00 | 4460.00 | 3020.00 | 9600.00 | |
| PS Ratio | 18.83 | 22.64 | 113.13 | 156.11 | 11855.95 | 140.44 | |
| PB Ratio | 2.06 | 2.10 | 3.42 | 2.73 | 1.57 | 4.24 | |
| P/TBV Ratio | 2.08 | 2.12 | 3.46 | 2.76 | 1.58 | 4.31 | |
| EV/Sales Ratio | 25.44 | 29.09 | 174.57 | 211.55 | 18235.34 | 138.77 | |
| Debt / Equity Ratio | 0.76 | 0.68 | 2.41 | 1.60 | 1.01 | 0.73 | |
| Asset Turnover | 0.04 | 0.05 | 0.01 | - | 0 | 0.03 | |
| Inventory Turnover | 1.06 | 1.28 | 0.89 | - | 0.00 | 0.14 | |
| Quick Ratio | 0.05 | 0.06 | 0.34 | 0.53 | 0.54 | 1.59 | |
| Current Ratio | 0.35 | 0.40 | 0.60 | 0.79 | 0.92 | 1.93 | |
| Return on Equity (ROE) | -24.43% | -26.55% | -34.26% | - | -44.30% | -74.70% | |
| Return on Assets (ROA) | -7.85% | -7.52% | -7.02% | - | -9.85% | -13.05% | |
| Return on Capital (ROIC) | -9.98% | -8.93% | -8.28% | - | -10.87% | -15.88% | |
| Return on Capital Employed (ROCE) | -24.90% | -20.10% | -17.00% | -18.50% | -16.20% | -15.00% | |
| Earnings Yield | -13.47% | -9.68% | -11.97% | -14.47% | -26.94% | -8.69% | |
| FCF Yield | -4.49% | -8.29% | -6.87% | -22.11% | -64.36% | -27.17% | |
| Buyback Yield / Dilution | -27.53% | -20.50% | -4.32% | -13.35% | -16.44% | -25.46% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.